Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lannett Company, a manufacturer of generic pharmaceuticals, has said that it is prepared to supply the US market with an uninterrupted and safe supply of digoxin tablets, following the voluntary recall of the drug by another generic drug manufacturer.
Subscribe to our email newsletter
The company has secured additional active pharmaceutical ingredient for its digoxin tablets, 0.125mg and 0.25mg. Digoxin is indicated for the treatment of mild to moderate heart failure as well as for the control of ventricular response rate in patients with chronic atrial fibrillation.
Arthur Bedrosian, president and CEO of Lannett, said: “We want to reassure all of our customers as well as the general public that we are prepared to supply this difficult to source medication.”